跳到正文
原文
STAT Pharma 医药频道· Ed Silverman·· 29 天前AI 评分51

Gilead 支付 4500 万美元和解得州总检察长提起的回扣指控

STAT+: Gilead to pay $45 million to settle kickback charges filed by Texas attorney general

AI 导读

Gilead Sciences 同意支付 4500 万美元,与得克萨斯州总检察长就回扣指控达成和解,指控称其不当影响得州 Medicaid 项目支付的处方。州政府与一名举报人共同推进该案,诉状指 Gilead 付费让另一公司聘请注册护士推荐其药品,并向医生提供免费支持服务,导致向政府项目提交虚假申报。

正文

By Ed Silverman

Oct. 22, 2026

Pharmalot Columnist, Senior Writer

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter.

Gilead Sciences agreed to pay $45 million to settle allegations of paying kickbacks that improperly influenced prescriptions paid for by the Texas Medicaid program, the latest pharmaceutical company to reach a deal with the state over marketing practices.

The state pursued its claims alongside a whistleblower who also filed a lawsuit claiming Gilead paid another company to hire registered nurses to recommend its drugs. The lawsuit also accused Gilead of offering free support services to doctors to prescribe its drugs, which resulted in false claims being filed with government programs.

Nearly a decade ago, Health Choice Advocates and some related firms filed whistleblower lawsuits against several drugmakers, accusing them of hiring third-party contractors to deploy nurses — sometimes by phone, sometimes at patient homes — to ensure that prescriptions were refilled.

STAT+ Exclusive Story

Already have an account? Log in

STAT+

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

来源:STAT Pharma 医药频道 · statnews.com